While packing for a move, the youngest son of columnist Cazandra Campos-MacDonald experiences a regular guest: joint pain.

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance ...

My Hate-Love Relationship with Hemophilia I don’t think anyone likes having a chronic disease. I have good days, and I have bad days. Thankfully, the good days outnumber the bad ones. There are days ...

Like many with hemophilia, columnist G Shellye Horowitz requires IV infusions of her medication — but the scars can raise some eyebrows.

Preventive treatment with Pfizer's Hympavzi can reduce bleeding rates in hemophilia A or B patients with inhibitors, new ...

Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study ...

A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Columnist G Shellye Horowitz struggles to find care for her gastrointestinal issues due to the shortage of medical providers ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her ...

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged period of time — that ...

Columnist Alliah Czarielle shares how, for her husband, who has hemophilia, finding strength requires acute self-awareness.